Sleep attack associated to rotigotine

Clinical Neuropharmacology

Volumn 32, Issue 6, 2009, Pages 364-365

  Garcia Ruiz, Pedro J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LISURIDE; PERGOLIDE; PIRIBEDIL; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; ROTIGOTINE; INDAN DERIVATIVE; NEUROPROTECTIVE AGENT; TETRALIN DERIVATIVE; THIOPHENE DERIVATIVE;

ADULT; CASE REPORT; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; HYPERSOMNIA; LETTER; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SLEEP ATTACK; SLEEP DISORDER; UNIFIED PARKINSON DISEASE RATING SCALE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HOSPITALIZATION; PATHOPHYSIOLOGY;

DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; DYSSOMNIAS; HUMANS; INDANS; LEVODOPA; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TETRAHYDRONAPHTHALENES; THIOPHENES;

EID: 74249089751     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/wnf.0b013e3181a946d5     Document Type: Letter

References (12)

1. Tanberg E, Larsen JP, Karlsen K. A community based study of sleep disturbances in patients with Parkinson's disease. Mov Disord. 1988;13:805-809.
2. Truong D, Bhidayasiri R, Wolters E. Management of non motor symptoms in advanced Parkinson's disease. J Neurol Sci. 2006;266:216-228.
3. Pal S, Bhattacharya KF, Agapito C, et al. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm. 2001;108:71-77.
4. Contin M, Provini F, Martinelli P, et al. Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoring. Clin Neuropharmacol. 2003;26:115-118.
5. Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: motor vehicle mishaps in person taking pramipexole and ropinirole. Neurology. 1999;52:1908-1911.
6. Ferreira JJ, Galitzky M, Montastruc JL, et al. Sleep attacks and Parkinson's disease treatment. Lancet. 2000;355:1333-1334.
7. Montastruc JL, Brefel-Courbon C, Senard JM, et al. Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clin Neuropharmacol. 2001;24:181-183.
8. Chaudhuri KR, Pal S, Brefel-Courbon C. FSleep attacks-or Funintended sleep episodes-occur with dopamine agonists: is this a class effect? Drug Saf. 2002;25:473-483.
9. Tan EK. Piribedil-induced sleep attacks in Parkinson's disease. Fundam Clin Pharmacol. 2003;17:117-119.
10. Hirayama M, Nakamura T, Hori N, et al. The video images of sleep attacks in Parkinson's disease. Mov Disord. 2008;23: 288-290.
11. The Parkinson Study Group. A controlled trial of rotigotine monotherapy in early Parkinson's disease. Arch Neurol. 2003;60: 1721-1728.
12. Jankovic J, Watts RL, Martin W, et al. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. Arch Neurol. 2007;64:676-682. (Pubitemid 46789833)